SCHEMBL7199463

SCHEMBL7199463

N#CCCOPCl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1328556 0.83 TDP1 (0.31)
SCHEMBL16327711 0.77 ALDH1A1 (0.41)
SCHEMBL28038699 0.72
SCHEMBL28235551 0.72
SCHEMBL14390529 0.72
SCHEMBL12105733 0.72
SCHEMBL12348388 0.72
SCHEMBL9241020 0.72
SCHEMBL19774819 0.69
SCHEMBL6559461 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112979704-A Voriconazole phosphocholine inner salt key intermediate and preparation method thereof 重庆西米瑞医药技术有限公司 2021-06-18 CN claimed
CN-119504896-A N-acetylgalactosamine modified pentaerythritol derivatives for oligonucleotide capping, methods of preparing the same, delivery compounds and nucleotide drugs 上海兆维科技发展有限公司 2025-02-25 CN disclosed
WO-2023192828-A2 COMPOSITIONS AND METHODS FOR THE TREATMENT OF ANGIOPOIETIN LIKE 7 (ANGPTL7) RELATED DISEASES EMPIRICO INC. (US) 2023-10-05 WO disclosed
WO-2023277168-A1 POLYNUCLEOTIDE AND MEDICINAL COMPOSITION 協和キリン株式会社 2023-01-05 WO disclosed
EP-3573718-B1 CYCLIC DINUCLEOTIDES AS STING AGONISTS JANSSEN BIOTECH INC (US) 2022-06-01 EP disclosed
EP-3919619-A1 MULTI-TARGETED SINGLE ENTITY CONJUGATES Alnylam Pharmaceuticals, Inc. (US) 2021-12-08 EP disclosed
CN-113004328-A Voriconazole phosphocholine inner salt intermediate, preparation method and method for preparing voriconazole phosphocholine inner salt 重庆西米瑞医药技术有限公司 2021-06-22 CN disclosed
CN-112979704-A Voriconazole phosphocholine inner salt key intermediate and preparation method thereof 重庆西米瑞医药技术有限公司 2021-06-18 CN disclosed
EP-3569711-B1 LIGAND-MODIFIED DOUBLE-STRANDED NUCLEIC ACIDS DICERNA PHARMACEUTICALS INC (US) 2021-02-03 EP disclosed
EP-3744350-A1 NUCLEIC ACID LINKED TO A TRIVALENT GLYCOCONJUGATE Silence Therapeutics GmbH (DE) 2020-12-02 EP disclosed
US-20150051167-A1 SUBSTITUTED NUCLEOSIDES, NUCLEOTIDES AND ANALOGS THEREOF Janssen Biopharma, Inc. 2015-02-19 US disclosed
US-20150011497-A1 SUBSTITUTED NUCLEOSIDES, NUCLEOTIDES AND ANALOGS THEREOF Janssen Pharmaceuticals, Inc. 2015-01-08 US disclosed
WO-2014209979-A1 SUBSTITUTED NUCLEOSIDES, NUCLEOTIDES AND ANALOGS THEREOF ALIOS BIOPHARMA, INC. (US) 2014-12-31 WO disclosed
US-8822671-B2 2'-O-modified RNA THE UNIVERSITY OF TOKYO (JP) 2014-09-02 US disclosed
US-20130253178-A1 2'-O-MODIFIED RNA THE UNIVERSITY OF TOKYO (JP) 2013-09-26 US disclosed
US-20130165400-A1 SUBSTITUTED NUCLEOSIDES, NUCLEOTIDES AND ANALOGS THEREOF ALIOS BIOPHARMA, INC. (US) 2013-06-27 US disclosed
US-6605708-B1 Stability HYBRIDON, INC. 2003-08-12 US disclosed
EP-0700449-A1 INVERSE LINKAGE OLIGONUCLEOTIDES FOR CHEMICAL AND ENZYMATIC PROCESSES BECKMAN INSTRUMENTS, INC. (US) 1996-03-13 EP disclosed
US-5462854-A Amenable to enzymatic elongation from either, or most preferably both termini under appropriate conditions and in presence of polymerase enzyme BECKMAN INSTRUMENTS, INC. (US) 1995-10-31 US disclosed
WO-1994024312-A2 INVERSE LINKAGE OLIGONUCLEOTIDES FOR CHEMICAL AND ENZYMATIC PROCESSES BECKMAN INSTRUMENTS, INC. (US) 1994-10-27 WO disclosed